Nuvation Bio Inc (NYSE: NUVB) is 94.04% higher on its value in year-to-date trading and has touched a low of $1.21 and a high of $4.16 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The NUVB stock was last observed hovering at around $3.01 in the last trading session, with the day’s loss setting it -0.08%.
Currently trading at $2.93, the stock is 18.98% and 14.87% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.94 million and changing -2.66% at the moment leaves the stock 6.80% off its SMA200. NUVB registered 127.13% gain for a year compared to 6-month loss of -11.21%. The firm has a 50-day simple moving average (SMA 50) of $2.5516 and a 200-day simple moving average (SMA200) of $2.73755.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 27.39% gain in the last 1 month and extending the period to 3 months gives it a 6.93%, and is 26.29% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.76% over the week and 6.88% over the month.
Nuvation Bio Inc (NUVB) has around 51 employees, a market worth around $989.07M and $2.16M in sales. Profit margin for the company is -24619.84%. Distance from 52-week low is 142.15% and -29.56% from its 52-week high. The company has generated returns on investments over the last 12 months (-105.67%).
The EPS is expected to shrink by -517.71% this year.
Nuvation Bio Inc (NUVB) Top Institutional Holders
201.0 institutions hold shares in Nuvation Bio Inc (NUVB), with institutional investors hold 60.30% of the company’s shares. The shares outstanding are 337.57M, and float is at 229.11M with Short Float at 4.94%. Institutions hold 44.10% of the Float.
The top institutional shareholder in the company is FMR LLC with over 28.82 million shares valued at $84.16 million. The investor’s holdings represent 13.1578% of the NUVB Shares outstanding. As of 2024-06-30, the second largest holder is ECOR1 CAPITAL, LLC with 19.21 million shares valued at $56.09 million to account for 8.7696 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 16.24 million shares representing 7.4124% and valued at over $47.41 million, while OMEGA FUND MANAGEMENT, LLC holds 6.0607 of the shares totaling 13.28 million with a market value of $38.77 million.
Nuvation Bio Inc (NUVB) Insider Activity
The most recent transaction is an insider purchase by Mashal Robert, the company’s Director. SEC filings show that Mashal Robert bought 100,000 shares of the company’s common stock on Oct 08 ’24 at a price of $2.20 per share for a total of $0.22 million. Following the purchase, the insider now owns 100000.0 shares.
Nuvation Bio Inc disclosed in a document filed with the SEC on Jun 25 ’24 that Cui Xiangmin (Director) bought a total of 277,895 shares of the company’s common stock. The trade occurred on Jun 25 ’24 and was made at $2.97 per share for $0.83 million. Following the transaction, the insider now directly holds 2.45 million shares of the NUVB stock.
Still, SEC filings show that on Jun 24 ’24, Cui Xiangmin (Director) acquired 336,874 shares at an average price of $2.98 for $1.0 million. The insider now directly holds 2,175,236 shares of Nuvation Bio Inc (NUVB).
